Increased Expression of IL-33 in Severe Asthma: Evidence of Expression by Airway Smooth Muscle Cells-Reference-Cited by-同舟云学术

Increased Expression of IL-33 in Severe Asthma: Evidence of Expression by Airway Smooth Muscle Cells

Published:2009-10-02 Issue:8 Volume:183 Page:5094-5103
ISSN:0022-1767
Container-title:The Journal of Immunology
language:en
Short-container-title:J Immunol

Author:

Préfontaine David,Lajoie-Kadoch Stéphane,Foley Susan,Audusseau Séverine,Olivenstein Ron,Halayko Andrew J.,Lemière Catherine,Martin James G.,Hamid Qutayba

Publisher

The American Association of Immunologists

Subject

Immunology,Immunology and Allergy

Reference45 articles.

1. Predominant TH2-like Bronchoalveolar T-Lymphocyte Population in Atopic Asthma

2. TNFalpha mRNA expression in allergic inflammation

3. Evidence of a Role of Tumor Necrosis Factor α in Refractory Asthma

4. TNF-α in asthma

5. Targeting TNF-α: A novel therapeutic approach for asthma

Cited by 455 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Neutralizing Oxidized Phosphatidylcholine Reduces Airway Inflammation and Hyperreactivity in a Murine Model of Allergic Asthma;Biology;2024-08-17

2. Interleukin-33 from oligodendrocytes sustains effector differentiation of tissue-resident CD8+ T cells and is a druggable target in CNS autoimmune disease;2024-07-13

3. Immunomodulatory effect of hemozoin from Opisthorchis felineus and its participation in reducing allergic inflammation through activation of the inflammasome;Russian Journal of Allergy;2024-06-16

4. Precision medicine for severe asthma – Biological targeted therapy;International Immunopharmacology;2024-06

5. Mast cells control lung type 2 inflammation via prostaglandin E2-driven soluble ST2;Immunity;2024-06